2.95
-0.175(-5.61%)
Currency In USD
| Previous Close | 3.12 |
| Open | 3.12 |
| Day High | 3.18 |
| Day Low | 2.91 |
| 52-Week High | 6.72 |
| 52-Week Low | 2.45 |
| Volume | 1.76M |
| Average Volume | 5.53M |
| Market Cap | 338.25M |
| PE | -3.17 |
| EPS | -0.93 |
| Moving Average 50 Days | 3.79 |
| Moving Average 200 Days | 3.8 |
| Change | -0.18 |
If you invested $1000 in Absci Corporation (ABSI) since IPO date, it would be worth $136.41 as of March 13, 2025 at a share price of $2.945. Whereas If you bought $1000 worth of Absci Corporation (ABSI) shares 3 years ago, it would be worth $393.72 as of March 13, 2025 at a share price of $2.945.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025
GlobeNewswire Inc.
Mar 04, 2025 9:05 PM GMT
VANCOUVER, Wash. and NEW YORK, March 04, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will report business updates and financial and operating results for t
Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.
Mar 04, 2025 9:00 PM GMT
VANCOUVER, Wash. and NEW YORK, March 04, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced that on March 3, 2025, the company granted a non-statutory stock option to purchas
Absci to Participate in the KeyBanc Capital Markets Healthcare Forum
GlobeNewswire Inc.
Mar 04, 2025 1:00 PM GMT
VANCOUVER, Wash. and NEW YORK, March 04, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the upcoming virtual KeyBanc Capital Markets